首页 | 本学科首页   官方微博 | 高级检索  
     

冠心病心绞痛病人血浆t—PA及其抑制物活性的测定
引用本文:王珍,林淑美,章政,王晓林. 冠心病心绞痛病人血浆t—PA及其抑制物活性的测定[J]. 齐鲁医学杂志, 2001, 16(2): 101-102
作者姓名:王珍  林淑美  章政  王晓林
作者单位:青岛大学医学院附属医院特需病房
摘    要:①目的探讨冠心病心绞痛病人血浆组织型纤溶酶原激活物(t-PA)及其抑制物(PAI)活性的变化及其可能机制.②方法采用显色底物法对20例冠心病心绞痛病人和20例健康人血浆t-PA及PAI的活性进行测定.③结果心绞痛病人血浆t-PA活性显著低于对照组(t=3.87,P<0.01),PAI活性明显高于对照组(t=2.63,P<0.05),65岁以上老年病人上述指标的异常变化尤为显著(t=3.87,2.98,P<0.01).④结论冠心病心绞痛病人存在纤溶系统功能异常,有可能在冠状动脉粥样硬化的基础上形成血栓.

关 键 词:心绞痛 组织型纤溶酶原激活物 纤溶酶原激活物抑制物 冠心病 t-PA
文章编号:1008-0341(2001)02-0101-02
修稿时间:2001-02-27

A STUDY ON THE DETERMINATION OF PLASMA t-PA AND PAI ACTIVITY IN CORONARY HEART DISEASE PATIENTS WITH ANGINA PECTORIS
WANG Zhen,LIN Shumei,ZHANG Zheng,et al. A STUDY ON THE DETERMINATION OF PLASMA t-PA AND PAI ACTIVITY IN CORONARY HEART DISEASE PATIENTS WITH ANGINA PECTORIS[J]. Medical Journal of Qilu, 2001, 16(2): 101-102
Authors:WANG Zhen  LIN Shumei  ZHANG Zheng  et al
Affiliation:WANG Zhen,LIN Shumei,ZHANG Zheng,et al Department of Special Medical Care,The Affiliated Hospital of Qingdao University Medical College,Qingdao 266003
Abstract:Objective To investigate the plasma tissue-type plasminogen activator(t-PA) and plasminogen activator inhibitor(PAI) in coronary heart disease patients with angina pectoris and its probable mechanism. Methods The plasma t-PA and PAI activity of coronary artery disease patients with angina pectoris were measured. Results The t-PA activity of the patients significantly decreased (t=3.87,P<0.01),and the PAI significantly higher than that of the healthy controls(t=2.63,P<0.05). The abnormal changes of the t-PA and PAI in patients more than 65 years old were more significant. Conclusion The patients with angina pectoris may have abnormal fibrinolysis and cause thrombosis on the basis of arteriosclerosis.
Keywords:angina pectoris  alteplase  plasminogen activator inhibitor
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号